1-4 of 4
Clemens B. Caspar
Close
Sort by
Journal Articles

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

Clinical Trials & Observations
John M. Timmerman, Debra K. Czerwinski, Thomas A. Davis, Frank J. Hsu, Claudia Benike, Zheng Mei Hao, Behnaz Taidi, Ranjani Rajapaksa, Clemens B. Caspar, Craig Y. Okada, Adrienne van Beckhoven, Tina Marie Liles, Edgar G. Engleman, Ronald Levy
Journal: Blood
Blood (2002) 99 (5): 1517–1526.
https://doi.org/10.1182/blood.V99.5.1517
Published: 2002
Journal Articles

Idiotype-encoding recombinant adenoviruses provide protective immunity against murine B-cell lymphomas

John M. Timmerman, Clemens B. Caspar, Stacie L. Lambert, Athanasia D. Syrengelas, Ronald Levy
Journal: Blood
Blood (2001) 97 (5): 1370–1377.
https://doi.org/10.1182/blood.V97.5.1370
Published: 2001
Journal Articles

Idiotype Vaccines for Non-Hodgkin's Lymphoma Induce Polyclonal Immune Responses That Cover Mutated Tumor Idiotypes: Comparison of Different Vaccine Formulations

Clemens B. Caspar, Shoshana Levy, Ronald Levy
Journal: Blood
Blood (1997) 90 (9): 3699–3706.
https://doi.org/10.1182/blood.V90.9.3699
Published: 1997
Journal Articles

Tumor-Specific Idiotype Vaccines in the Treatment of Patients With B-Cell Lymphoma — Long-Term Results of a Clinical Trial

Frank J. Hsu, Clemens B. Caspar, Debra Czerwinski, Larry W. Kwak, Tina Marie Liles, Athanasia Syrengelas, Behnaz Taidi-Laskowski, Ronald Levy
Journal: Blood
Blood (1997) 89 (9): 3129–3135.
https://doi.org/10.1182/blood.V89.9.3129
Published: 1997